ResMed | RMD - 税前利润

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	税前利润	更改		日
Ansell	USD 33.35M		74.15M	2025-06
Artivion	USD 11.4M		7.84M	2025-12
AtriCure	USD 394K		1.97M	2026-03
Baxter International	USD -756M		877M	2025-12
Cochlear	AUD 121.1M		155.6M	2025-06
Cooper Companies	USD 116.8M		137.4M	2025-09
CSL	USD 2.61B		1.21B	2025-12
Dexcom	USD 340.7M		40.7M	2025-12
Edwards Lifesciences	USD 348.4M		51.8M	2025-09
Fisher Paykel Healthcare	NZD 296.9M		90.5M	2025-06
Globus Medical	USD 169.23M		25.24M	2025-12
Haemonetics	USD 59.97M		8.69M	2025-12
Idexx Laboratories	USD 355.44M		48.46M	2026-03
Inogen	USD -6.06M		467K	2024-09
Insulet	USD 113M		27.2M	2026-03
Integra LifeSciences	USD -2.41M		6.72M	2026-03
Intuitive Surgical	USD 955.6M		100.4M	2025-12
Masimo	USD 71.3M		3.6M	2026-03
Medtronic	USD 2.1B		224M	2025-09
Philips	EUR 466M		191M	2025-12
Ramsay Health Care	AUD 103.75M		54.35M	2025-06
ResMed	USD 496.15M		13.77M	2025-12
Sigma Healthcare	AUD 8.15M		7.4M	2024-07
Sonic Healthcare	AUD 402.01M		53.16M	2025-06
Steris	USD 257.8M		66.6M	2025-12
Teleflex	USD 218.94M		657.52M	2025-12
Thermo Fisher Scientific	USD 2.12B		295M	2025-12